Document is current
Any future updates will be listed below
-
Authors
Okano, Naohiro https://orcid.org/0000-0002-4098-5217
Morizane, Chigusa
Nomura, Shogo
Takahashi, Hideaki
Tsumura, Hidetaka
Satake, Hironaga
Mizuno, Nobumasa
Tsuji, Kunihiro
Shioji, Kazuhiko
Asagi, Akinori
Yasui, Kohichiroh
Kitagawa, Sho
Kashiwada, Tomomi
Ishiguro, Atsushi
Kanai, Masashi
Ueno, Makoto
Ogura, Takashi
Shimizu, Satoshi
Tobimatsu, Kazutoshi
Motoya, Masayo
Nakashima, Koji
Ikeda, Masafumi
Okusaka, Takuji
Furuse, Junji
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (16ck0106084h0003)
- License Information
-
More Information
Article History
Received: 11 April 2020
Accepted: 2 June 2020
First Online: 13 June 2020
Compliance with ethical standards
:
: Morizane C. received research funding from Yakult Honsha, and Eli Lilly Japan. Satake H. received honoraria from Eli Lilly Japan. Mizuno N. received research funding from Dainippon Sumitomo Pharma, MSD, ASLAN Pharmaceuticals, Incyte, and Yakult Honsha. Kanai M received from honoraria from Chugai Pharmaceutical. Shimizu S. received research funding from Yakult Honsha.Ikeda M. received honoraria from Eli Lilly Japan, and received research funding from Yakult Honsha. Okusaka T. received research funding from AstraZeneca, Chugai Pharmaceutical, Eisai, Novartis Pharma, and Bristol-Myers. Furuse J. received honoraria and research funding from Yakult Honsha, and Eli Lilly Japan. The other authors declare that they have no conflict of interest.
: The study was performed in accordance with the ethical standards established in the 1964 Declaration of Helsinki and its later amendments. The study was approved by the institutional review board of each study site, and all the patients provided informed consent prior to their inclusion in the study.
